Companies like AG1, Ritual and Blueland are investing in clinical research as a way to fuel brand growth. Executives at these companies share why they think it's an important differentiator.
Lululemon reported second-quarter earnings on Thursday that came in below expectations, with executives facing plenty of questions from Wall Street analysts about whether or not the activewear brand had correctly diagnosed the challenges it faces.
